| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 27,23% | 37,02% | -15,20% | · |
| SCHRODER ISF GLOBAL EQUITY YIELD C ACC USD | RVI GLOBAL VALOR | 27,23% | 56,12% | 69,56% | 145,62% |
| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) (EUR HEDGED) QL-ACC | RVI GLOBAL VALOR | 27,23% | 68,40% | 66,26% | · |
| FRANKLIN TECHNOLOGY I (YDIS) EUR | RVI TECNOLOGÍA | 27,22% | 110,62% | 66,96% | · |
| ISHARES MSCI JAPAN ESG SCREENED UCITS ETF USD (DIST) | RVI JAPÓN | 27,22% | 58,87% | 47,78% | · |
| PRIVILEDGE - AMERICAN CENTURY EMERGING MARKETS EQUITY (USD) P CAP | RVI EMERGENTES | 27,22% | 78,32% | 22,39% | · |
| THEAM QUANT - EQUITY WORLD GURU PRIVILEGE EUR CAP | RVI GLOBAL | 27,22% | 88,38% | 107,65% | · |
| NORDEA 2 - BETAPLUS ENHANCED EMERGING MARKETS EQUITY FUND BN-USD | RVI EMERGENTES | 27,21% | · | · | · |
| BGF NEXT GENERATION TECHNOLOGY Z2 CHF (HEDGED) | RVI TECNOLOGÍA | 27,20% | 109,78% | 19,79% | · |
| INVESCO JAPANESE EQUITY ADVANTAGE A DIS ANNUAL USD | RVI JAPÓN | 27,20% | · | · | · |
